{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:47:33Z","timestamp":1777297653252,"version":"3.51.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine"},{"name":"National Major Science and Technology Research Projects for the Control and Prevention of Major Infectious Diseases of China"},{"name":"Health Research & Special Projects"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.cca.2018.09.012","type":"journal-article","created":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T17:02:17Z","timestamp":1536339737000},"page":"96-100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Prevalence and influencing factors of the high nil-control spot count in T-SPOT.TB: A matched case-control study"],"prefix":"10.1016","volume":"487","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3697-6737","authenticated-orcid":false,"given":"Xiaochuan","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijun","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8162-0903","authenticated-orcid":false,"given":"Xiaoqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2018.09.012_bb0005","author":"WHO"},{"key":"10.1016\/j.cca.2018.09.012_bb0010","unstructured":"CDC: Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection. MMWR 59(RR-5): 1\u201326."},{"issue":"10","key":"10.1016\/j.cca.2018.09.012_bb0015","first-page":"265","article-title":"Tuberculosis trends\u2014United States, 2014","volume":"64","author":"Scott","year":"2015","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"10","key":"10.1016\/j.cca.2018.09.012_bb0020","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S1473-3099(17)30402-4","article-title":"Incidence of active tuberculosis in individuals with latent tuberculosis infection in rural China: follow-up results of a population-based, multicentre, prospective cohort study","volume":"17","author":"Lei","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"22","key":"10.1016\/j.cca.2018.09.012_bb0025","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMra1405427","article-title":"Latent Mycobacterium tuberculosis infection","volume":"372","author":"Campion","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.cca.2018.09.012_bb0030","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1183\/09031936.00117207","article-title":"Indeterminate test results of T-SPOTTM.TB performed under routine field conditions","volume":"31","author":"Beffa","year":"2008","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.cca.2018.09.012_bb0035","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/thoraxjnl-2015-207811","article-title":"Effect of immunosuppressive therapy on interferon gamma release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis","volume":"71","author":"Wong","year":"2016","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.cca.2018.09.012_bb0040","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1378\/chest.09-2350","article-title":"Evidence-based comparison of commercial interferon-\u03b3 release assays for detecting active TB","volume":"137","author":"Diel","year":"2010","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.cca.2018.09.012_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032482","article-title":"Interferon-\u03b3 release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis","volume":"7","author":"Santin","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cca.2018.09.012_bb0050","first-page":"286","article-title":"Use of T-SPOT.TB in latent tuberculosis infection diagnosis in general and immunosuppressed populations","volume":"30","author":"Piana","year":"2007","journal-title":"New Microbiol."},{"issue":"3","key":"10.1016\/j.cca.2018.09.012_bb0055","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/aid.2010.0062","article-title":"T-SPOT.TB in the diagnosis of active tuberculosis among HIV-infected patients with advanced immunodeficiency","volume":"27","author":"Chen","year":"2011","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.cca.2018.09.012_bb0060","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2334-9-15","article-title":"Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals","volume":"9","author":"Talati","year":"2009","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cca.2018.09.012_bb0065","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/1471-2334-11-319","article-title":"Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB\u2122) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-infection","volume":"11","author":"Elzi","year":"2011","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.cca.2018.09.012_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3947\/ic.2013.45.1.44","article-title":"Indeterminate T-SPOT.TB Test results in patients with suspected extrapulmonary tuberculosis in routine clinical practice","volume":"45","author":"Lee","year":"2013","journal-title":"Infect Chemother."},{"key":"10.1016\/j.cca.2018.09.012_bb0075","unstructured":"Oxford Immunotec. Package Insert for In Vitro Diagnostic Use. http:\/\/www.oxforddiagnosticlaboratories.eu\/wp-content\/media\/PI-TB-IVD-UK-v3.pdf. Date last accessed: Dec 1 2017."},{"key":"10.1016\/j.cca.2018.09.012_bb0080","series-title":"Oxford Handbook of Critical Care. Oxford","author":"Webb","year":"2005"},{"issue":"1\u20132","key":"10.1016\/j.cca.2018.09.012_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jim.2005.01.013","article-title":"Effect of sample handling on analysis of cytokine responses to Mycobacterium tuberculosis in clinical samples using ELISA, ELISPOT and quantitative PCR","volume":"298","author":"Doherty","year":"2005","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"10.1016\/j.cca.2018.09.012_bb0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2169\/internalmedicine.48.1432","article-title":"Clinical Evaluation of the T-SPOT.TB Test for patients with Indeterminate results on the QuantiFERON TB-2G Test","volume":"48","author":"Kobashi","year":"2009","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.cca.2018.09.012_bb0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.cellimm.2014.06.003","article-title":"Interleukin-28A promotes IFN-gamma production by peripheral blood mononuclear cells from patients with Behcet's disease","volume":"290","author":"Li","year":"2014","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.cca.2018.09.012_bb0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/03009742.2012.704391","article-title":"Elevated levels of interleukin-27 and effect on production of interferon-gamma and interleukin-17 in patients with Behcet's disease","volume":"42","author":"Shen","year":"2013","journal-title":"Scand. J. Rheumatol."},{"issue":"6","key":"10.1016\/j.cca.2018.09.012_bb0105","first-page":"996","article-title":"Increased frequencies of interleukin-2- and interferon-\u03b3-producing T cells in patients with active Behcet's disease","volume":"39","author":"Nakako","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"12","key":"10.1016\/j.cca.2018.09.012_bb0110","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.3899\/jrheum.130303","article-title":"Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-gamma release assay results","volume":"40","author":"Costantino","year":"2013","journal-title":"J. Rheumatol."},{"issue":"9","key":"10.1016\/j.cca.2018.09.012_bb0115","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.4049\/jimmunol.170.9.4833","article-title":"Inhibition of IFN-gamma signaling by glucocorticoids","volume":"170","author":"Hu","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.cca.2018.09.012_bb0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1196\/annals.1321.010","article-title":"Glucocorticoids and the Th1\/Th2 balance","volume":"1024","author":"Elenkov","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.cca.2018.09.012_bb0125","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1365-2362.2011.02502.x","article-title":"Predictors of indeterminate IFN-gamma release assay in screening for latent TB in inflammatory bowel diseases","volume":"41","author":"Papay","year":"2011","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.cca.2018.09.012_bb0130","article-title":"Effects of acute critical illnesses on the performance of interferon-gamma release assay","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cca.2018.09.012_bb0135","first-page":"126","article-title":"Numerical and functional deficiency in T helper cells in protein energy malnutrition","volume":"51","author":"Chandra","year":"1983","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.cca.2018.09.012_bb0140","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1128\/CDLI.12.4.502-507.2005","article-title":"Assessment by flow cytometry of cytokine production in malnourished children","volume":"12","author":"Rodr\u00edguez","year":"2005","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"4","key":"10.1016\/j.cca.2018.09.012_bb0145","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/rccm.201201-0026OC","article-title":"Identifying predictors of interferon-\u03b3 release assay results in pediatric latent tuberculosis: a protective role of Bacillus Calmette-Gu\u00e9rin?","volume":"186","author":"Roy","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"1","key":"10.1016\/j.cca.2018.09.012_bb0150","doi-asserted-by":"crossref","first-page":"7764","DOI":"10.1038\/s41598-017-07785-6","article-title":"Analysis of factors influencing diagnostic accuracy of T-SPOT.TB for active tuberculosis in clinical practice","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118304893?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898118304893?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T05:53:08Z","timestamp":1604901188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898118304893"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":30,"alternative-id":["S0009898118304893"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2018.09.012","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and influencing factors of the high nil-control spot count in T-SPOT.TB: A matched case-control study","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2018.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}